Parkinson's Progression Markers Initiative (PPMI)

Parkinson's Progression Markers Initiative (PPMI)

United States; Michigan United States; Americas; North America; Great Lakes
Is it you?
Investor info
Type
Foundations
Stage focus
  • Early stage VC
Industry focus
Description
The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study launched by The Michael J. Fox Foundation to identify biomarkers of Parkinson’s disease progression and to accelerate new therapies.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Health & Wellness (LOHAS)
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.